StockData

China SXT Pharmaceuticals, Inc. (SXTC) stock

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$2.86−0.13 (-4.35%)

Close on Nov 17, 2026Market cap $2.74MP/E –Yield –

China SXT Pharmaceuticals r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2024 it was $184.19K, down 8.2% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2024Mar 31, 2024$184.19K-8.2%
FY2023Mar 31, 2023$200.72K-45.3%
FY2022Mar 31, 2022$367.01K–

More China SXT Pharmaceuticals figures

See a number that looks wrong?